Electrical stimulation and non-contact ultrasound sit on Medicare's coverage chart as adjunct wound therapies, not first-line treatment, and an audit reads the chart for that order. The Centers for Medicare & Medicaid Services covers electrical stimulation only for chronic Stage III or Stage IV pressure ulcers, arterial ulcers, diabetic ulcers, and venous stasis ulcers, and only after standard wound care has already failed for 30 days. Low-frequency, non-contact, non-thermal ultrasound, marketed clinically as MIST Therapy, has no national coverage policy at all; each Medicare Administrative Contractor sets its own documentation bar through a Local Coverage Determination. A claim that skips the sequencing, or keeps billing after the therapy stops showing results, is the claim an audit catches first.

Electrical Stimulation Under NCD 270.1

National Coverage Determination 270.1 limits electrical stimulation and electromagnetic therapy for wounds to four wound types: chronic Stage III or Stage IV pressure ulcers, arterial ulcers, diabetic ulcers, and venous stasis ulcers. A wound counts as chronic once it has not healed within 30 days of occurring. Neither therapy is covered as the initial treatment. Coverage starts only after the record shows at least 30 days of standard wound therapy, meaning optimized nutritional status, debridement to remove devitalized tissue, a clean and moist bed of granulation tissue under appropriate dressings, and treatment of any infection, with no measurable signs of improved healing during that period. Once treatment begins, the treating physician must evaluate the wound at least monthly, and coverage stops when the wound reaches a 100% epithelialized bed or when a full 30-day period passes without measurable healing. The same failed-conservative-care threshold runs through other advanced wound therapies Medicare covers; Conservative Care Requirements Before Advanced Therapy walks through how that trial is documented for skin substitute grafts and hyperbaric oxygen.

Ultrasound Therapy Runs on Local MAC Rules

Each Medicare Administrative Contractor decides low-frequency, non-contact, non-thermal ultrasound wound therapy coverage on its own, through a Local Coverage Determination, because no national policy governs it. WPS's LCD L37228 and Novitas's LCD L35125 are two current examples; Novitas's LCD covers the therapy when a wound meets Medicare's debridement criteria but sharp or excisional debridement is contraindicated and documented as such, when the wound is too painful for sharp debridement and has already failed conventional debridement, or when 30 days of standard wound care has produced no documented improvement, while WPS's LCD does not restate those criteria but shares the same outcome checkpoints. Novitas's LCD allows two to three sessions a week, and both LCDs cap it at no more than 18 services within a six-week period, and both require observable, documented improvement, in pain, necrotic tissue, wound size, or granulation tissue, within the first six treatments. Continuing the therapy past that checkpoint without documented improvement is not reasonable and necessary under either LCD's own terms. Because the policy is local, identical documentation can clear one MAC's bar and fail another's, the same jurisdictional split Wound Care LCD Compliance Across MAC Jurisdictions describes for skin substitute coverage.

Medicare covers electrical stimulation and ultrasound wound therapy only as adjuncts to failed standard care, and an audit reads the chart for that sequence before it reads the result.

Where Audits Catch These Claims

Auditors reviewing electrical stimulation or ultrasound wound therapy claims look first for sequencing. A claim billed before the chart documents a completed 30-day trial of standard wound care, with no measurable healing, fails on its face. So does a claim for electrical stimulation missing the treating physician's required monthly evaluation, or continuing past a 30-day period without new evidence of healing. For MIST Therapy, the same scrutiny applies to the six-treatment improvement checkpoint and the 18-service cap within six weeks, and to billing the ultrasound session on the same date as other active wound management or debridement, which WPS's LCD treats as not separately billable. A chart that cannot show the contraindication to sharp debridement that Novitas's LCD requires for ultrasound coverage, stated specifically rather than implied, is a chart an auditor can deny on documentation alone.

Why Early Legal Counsel Is Critical

It is critical that wound care providers promptly retain experienced healthcare defense counsel upon receiving an audit notice, additional documentation request, or other government inquiry tied to electrical stimulation or ultrasound wound therapy billing. Early legal intervention can protect the provider's rights, ensure an accurate response to the auditor's request, avoid inadvertent admissions, preserve relevant defenses, and allow counsel to communicate with the auditor directly. Delaying representation can significantly affect the outcome of a matter.

How Health Law Alliance Can Help

Health Law Alliance's attorneys have overseen 2,000+ audits and handled 5,000+ matters, with 25+ years of experience.

If your practice has received an audit notice or documentation request tied to electrical stimulation, ultrasound, or another adjunct wound therapy, contact Health Law Alliance's wound care audit defense attorneys for a free, confidential consultation before you respond.